Twist, Centogene to develop rare disease assay kits

By The Science Advisory Board staff writers

Twist Bioscience and Centogene have signed a contract to collaborate on the development and commercialization of custom assay kits for rare diseases.

The kits will be designed to make genetic testing more accessible to patients and add to the understanding of rare diseases. Their collaboration aims to augment the bio databank on rare diseases and may contribute to the discovery and development of new therapies to treat these diseases in the future, the companies said.

Copyright © 2021

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking